Competitive: Galderma: It's an exciting time for GALDERMA as we enter the biologics market in Dermatology. This is GALDERMA's first entrance into the...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - FINANCIALPOST.COM - A La Une - 13/Aug 05:05
Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis
Ad hoc announcement pursuant to Art. 53 LR Nemluvio® (nemolizumab) is the first approved monoclonal antibody specifically inhibiting the signaling of IL-31, a neuroimmune cytokine that drives multiple disease mechanisms in prurigo nodularis1-3 Prurigo nodularis is a chronic skin condition that is estimated to affect up to 181,000 people in the United States, and […]
Articles similaires
Galderma: Medical Science Liaison - Atopic Dermatitis and Prurigo Nodularis (Biologics) - South
pharmiweb.com - 29/Aug 00:00
Competitive: Galderma: It's an exciting time for GALDERMA as we enter the biologics market in Dermatology. This is GALDERMA's first entrance into the...
Novel monoclonal antibody appears effective at neutralizing numerous SARS-CoV-2 variants
news.medical.net - 06/Sep 16:33
A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a...
Monoclonal Antibody Tops Placebo for Reducing Migraine Frequency
drugs.com - 04/Sep 23:07
WEDNESDAY, Sept. 4, 2024 -- The humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand,...
New biomedical device promises noninvasive treatment of chronic pain
theparadise.ng - 29/Aug 17:45
The sensation of pain is an essential biological signal, but when it becomes persistent and overwhelming, it can significantly impact one’s quality...
Alzheimer's Drugs May Work in Whole New Way, Study Finds
drugs.com - 09:09
THURSDAY, Sept. 11, 2024 -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been...
#HEALTH: More Malaysians facing chronic kidney disease
nst.com.my - 30/Aug 13:32
THE numbers speak for themselves. Chronic kidney disease (CKD) is a burden that may overwhelm Malaysian healthcare in the years to come.
JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab
zacks.com - 30/Aug 16:07
The Johnson & Johnson filing seeks the FDA's approval for nipocalimab to treat generalized myasthenia gravis in a broad population of...
Les derniers communiqués
-
Four Seasons to Expand Saudi Arabian Portfolio Alongside Dar Al Omran Company with New Hotel in Madinah
Four Seasons Hotels and Resorts - 07/05/2024
-
Four Seasons Yachts Unveils Inaugural Itineraries to the Caribbean and Mediterranean and a First Look at its 95 Spectacular Suites
Four Seasons Hotels and Resorts - 27/03/2024
-
Visual 01Elevating Excellence: Four Seasons Embarks on the Next Stage of Strategic Global Growth
Four Seasons Hotels and Resorts - 22/01/2024